Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence
Open Access
- 18 April 2008
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 3 (1) , 1-10
Abstract
Background: The extent of enhanced bone marrow angiogenesis in chronic lymphocytic leukemia (CLL) and relationship to proangiogenic factors and prognostic indicators is largely unexplored. Methods: To further investigate the role of angiogenesis in CLL by evaluating the topography and extent of angiogenesis in a group of CLL bone marrow biopsies, to study the expression of pro and antiangiogenic vascular factors in CLL cells to more precisely document the cell types producing these factors, and to evaluate the role, if any, of localized hypoxia in upregulation of angiogenesis in CLL We used immunohistochemistry (IHC) (n = 21 pts) with antibodies to CD3 and CD20, proangiogenic (VEGF, HIF-1a) and antiangiogenic (TSP-1) factors, and VEGF receptors -1 and -2 to examine pattern/extent of CLL marrow involvement, microvessel density (MVD), and angiogenic characteristics; flow cytometry (FC) was performed on 21 additional cases for VEGF and TSP-1. Results: CLL patients had higher MVD (23.8 vs 14.6, p~0.0002) compared to controls (n = 10). MVD was highest at the periphery of focal infiltrates, was not enhanced in proliferation centers, and was increased irrespective of the presence or absence of cytogenetic/immunophenotypic markers of aggressivity. By IHC, CLL cells were VEGF(+), HIF-1a (+), TSP-1(-), VEGFR-1(+), and VEGFR-2(+). By FC, CLL cells were 1.4–2.0-fold brighter for VEGF than T cells and were TSP-1(-). Conclusion: CLL demonstrates enhanced angiogenesis, with increased MVD, upregulated VEGF and downregulated TSP-1. Upregulation of HIF-1a in all CLL cases suggests localized tissue hypoxia as an important stimulant of microvessel proliferation. The presence of VEGF receptors on CLL cells implies an autocrine effect for VEGF. Differences in MVD did not correlate with traditional genetic/immunophenotypic markers of aggressiveness.Keywords
This publication has 38 references indexed in Scilit:
- Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumorsJournal of Cellular Biochemistry, 2004
- The HIF family member EPAS1/HIF-2α is required for normal hematopoiesis in miceBlood, 2003
- Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemiaLeukemia, 2003
- Role of Vascular Endothelial Growth Factor in Bone Marrow Stromal Cell Modulation of Endothelial CellsTissue Engineering, 2003
- Mast cells and angiogenesisMicroscopy Research and Technique, 2002
- Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemiaBlood, 2002
- B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic moleculesLeukemia, 2002
- Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migrationJournal of Clinical Investigation, 2000
- Assignment of Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PlGF) Genes to Human Chromosome 6p12–p21 and 14q24–q31 Regions, RespectivelyGenomics, 1996
- Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblastsCytometry, 1991